October 25, 2025
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: How stereo-correct data can de-risk AI-driven drug discovery
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > How stereo-correct data can de-risk AI-driven drug discovery
Drug development

How stereo-correct data can de-risk AI-driven drug discovery

By Newsroom
Last updated: October 19, 2025
1 Min Read
Share


Image: Wikimedia Commons (Public Domain)

Image: Wikimedia Commons (Public Domain)

In drug discovery, the difference between a breakthrough and a breakdown can be as small as the twist of a bond. Stereochemistry, the three-dimensional arrangement of atoms, governs how otherwise identical molecules behave in the body: whether they bind the intended target, trigger off-targets, or get cleared in minutes rather than hours.

Adam Sanford

Adam Sanford, Ph.D.

“Shape really does matter,” said Adam Sanford, Ph.D., senior product lead at scientific…



Source link

TAGGED:AI drug designchiralitycomputational chemistrydata qualityDrug discoveryenantiomersFDA approvalMachine Learningmolecular modelingQSARstereochemistrythalidomide
Share This Article
Facebook Email Copy Link Print

HOT NEWS

First Quarterly Stormwater Sampling Deadline of 2025 Approaching

Environmental Science
April 5, 2025

Executive Brief: Compliant Targeting Ailment-Specific…

Compliant Targeting Ailment-Specific Audiences The Challenge: Healthcare and pharmaceutical companies face a critical challenge: reaching consumers…

October 24, 2025

As Part of the “AfriSummit 2024” Activities A High-Level Meeting between Uganda and Egypt to Strengthen Pharmaceutical Cooperation and Expand the African Market

A high-level meeting between Uganda and Egypt to strengthen pharmaceutical cooperation CAIRO, Egypt (AfricaNewswire.Net) —…

April 5, 2025

ضمن فعاليات “قمة إفريقيا للشؤون التنظيمية 2024” اجتماع رفيع بين أوغندا ومصر لتعزيز التعاون الدوائي وتوسيع السوق الإفريقية

اجتماع رفيع المستوى بين أوغندا ومصر لتعزيز التعاون الصيدلاني القاهرة، مصر، نوفمبر 2024 (AfricaNewswire.Net)  في…

April 5, 2025

YOU MAY ALSO LIKE

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes | Certara …

Drug development
April 5, 2025

eCTD 4.0: When & Where it will be Implemented Next

Major health authorities around the world are implementing or preparing to implement the next major version of eCTD for regulatory…

Drug development
April 12, 2025

Model-informed Drug Development in Oncology

MIDD can be applied to all therapeutic areas. This blog highlights its application to oncology drug development. This approach can…

Drug development
May 3, 2025

Absci becomes clinical-stage company with clinical trial initiation

Biopharmaceutical company Absci has transitioned into a clinical-stage organisation with the dosing of patients in its Phase I clinical trial…

Drug development
June 6, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Executive Brief: Compliant Targeting Ailment-Specific…
October 24, 2025
Webinar: Building the leadership teams that launch in Europe
October 24, 2025
Israel vertuscht kritische Treffer + China mit krasser Kriegs-Drohung + EU-Sanktionen gegen Israel!
October 24, 2025
How to accelerate time-to-insight with better RWD
October 24, 2025

Life Science Magazines

Executive Brief: Compliant Targeting Ailment-Specific…
October 24, 2025
Webinar: Building the leadership teams that launch in Europe
October 24, 2025
How to accelerate time-to-insight with better RWD
October 24, 2025
How multimodal data is transforming drug discovery
October 23, 2025

LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?